April 2026 —— The quality of a premium active ingredient is determined not only by its chemical purity, but also by the precise control of its microphysical properties—including polymorphism, particle size distribution (PSD), and bulk density. To support these standards, Boweixin Biotech announced the official commissioning of its upgraded Advanced Analytical and Testing Center. The company has invested in analytical instrumentation, including high-resolution X-ray Powder Diffractometers (XRPD), Differential Scanning Calorimeters (DSC), and laser particle size analyzers, to establish a leading-edge laboratory dedicated to NMN (CAS 1094-61-7) polymorphic and solid-state characterization.
Instrument-Driven Quality Assurance
In polymorphic systems, even a 1% trace contamination of an inactive, metastable crystal phase can lead to physical degradation, caking, or altered dissolution profiles in the final product.
The newly commissioned solid-state chemistry laboratory serves as the final quality gate for Boweixin’s NMN:
- XRPD Fingerprint Analysis: This technology monitors characteristic Bragg diffraction peaks, distinguishing between the active β-isomer and inactive α-conformations within seconds to ensure consistent composition.
- Thermal Stability Profiles (DSC/TGA): These instruments evaluate thermodynamic behavior under varying thermal gradients, predicting raw material performance under long-term logistics and storage stresses.
- Particle Size Optimization (PSD): This system ensures that the particle size range (D50, D90) of every batch meets narrow, predefined specifications, supporting reliable blending and formulation.
Transparent Analytical Data Accelerates Brand R&D
“Our laboratory operates with total transparency, integrating advanced solid-state characterization directly into every Certificate of Analysis (CoA) we release,” commented the Director of the Analytical Center. The upgraded facility is fully prepared to support on-site audits and quality reviews from international buyers and pharmaceutical compliance teams. Additionally, we offer custom polymorphic validation and formulation compatibility testing for key clients, helping to accelerate their formulation development and bioequivalence (BE) trial timelines.
